FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

West-ward Pharmaceutical Lisinopril and Hydrochlorothiazide Tablets Recall

Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count table…

West-ward Pharmaceutical Corp. · Eatontown, NJ

Risk level
Class II
Reported by FDA
Jan 30, 2013
Recall ID
D-132-2013
Check your lot numberHow we source this data

Summary

West-ward Pharmaceutical recalled Lisinopril and Hydrochlorothiazide Tablets starting Nov 30, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-132-2013 on Jan 30, 2013. Reason: Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets. Status: Terminated.

Why it was recalled

Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.

Product description

Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

Lot numbers, UPCs & expiration codes

Lot #: 69392A, 69393A, 69394A, 69395A, 69396A, 69397A , Exp 09/15; 69495A, 69496A, 69497A, 69498A, 69524A, 69525A, Exp 10/15

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-132-2013
Classification
Class II
Status
Terminated
Recall initiated
Nov 30, 2012
FDA report date
Jan 30, 2013
Quantity
43,478 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
West-ward Pharmaceutical Corp.

Original FDA data

Every field from FDA enforcement report D-132-2013, exactly as published.

Show all FDA fields
City
Eatontown
State
NJ
Status
Terminated
Country
United States
Event ID
63967
Address
465 Industrial Way W
Code information
Lot #: 69392A, 69393A, 69394A, 69395A, 69396A, 69397A , Exp 09/15; 69495A, 69496A, 69497A, 69498A, 69524A, 69525A, Exp 10/15
Postal code
07724-2209
Report date
Jan 30, 2013
Product type
Drugs
Recall number
D-132-2013
Classification
Class II
Recalling firm
West-ward Pharmaceutical Corp.
Product quantity
43,478 bottles
Termination date
Jul 9, 2014
Reason for recall
Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1264-01) and b) 1000-count tablets per bottle (NDC 0143-1264-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Nov 30, 2012
Initial firm notification
Letter
Center classification date
Jan 18, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-132-2013, published Jan 30, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls